This difference is quite significant as it determines whether these patients should receive postoperative adjuvant therapy.
← all excerpts
The prognosis and treatment consideration for non-small cell lung carcinoma patients with tumor size of >2.0-3.0 cm and visceral pleural invasion: a SEER-based study.
1
—
—